Systematic review of the complications of treatment delivery devices for cancer patients
Supporting Agencies
- Departamento de Enfermería. Facultad de Medicina y Enfermería. Universidad de Córdoba.
Abstract
Objetives: To know the scientific production releated with the delivery treatment devices to the oncology patients and to know the main complications of central venous catheters with reservoir (Port-A-Cath) and Percutaneously Inserted Central Catheters (PICC).Methods: Systematic review of the scientific literature in databases, whose data collection was realized from January to May 2015.
Results: 124 articles were selected by its title and abstract. 42 documents of them had the inclusion criteria. Port-A-Cath scientific production is greater than PICC’s and infectious and thrombotic complications are the most common in both devices.
Conclusions: Most complications can be prevented because their development is due to errors in the implementation of the device or due to inappropriate care. It is difficult knowing which device provides better quality of life, although patients usually perfer Port-A-Cath because of its aesthetic result.
Downloads
References
Cancer.org [Internet]. American Cancer Society; c2015 [citado 4 abr 2015]. Disponible en: http://www.cancer.org/index
Cancer.gov [Internet]. National Cancer Institute; c2015 [citado 4 abr 2015]. Disponible en: http://www.cancer.gov/
Seom.org [Internet]. Madrid: Sociedad Española de Oncología Médica; [citado 4 abr 2015]. Las Cifras del Cáncer en España 2014; 20. Disponible en: http://www.seom.org/seomcms/images/stories/recursos/Las_cifras_del_cancer_2014.pdf
Aecc.es [Internet]. Madrid: Asociación Española Contra el Cáncer; [actualizado 4 abr 2015; citado 5 abr 2015]. Disponible en: https://www.aecc.es/Paginas/PaginaPrincipal.aspx
Patel GS, Jain K, Kumar R, Strickland AH, Pellegrini L, Slavotinek J, et al. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. Support Care Cancer. 2014;22(1):121-8.
Cortés-Flores AO, Morgan-Villela G, Juárez-Uzeta EA, Fuentes-Orozco C, Jiménez-Tornero J, González-Ojeda A. Dispositivos de acceso venoso central totalmente implantables en pacientes con cáncer. Experiencia en un Centro Oncológico Privado. Cir Cir 2012;80:429-434.
Alvarez JA, Villalba WO, Encina WP, Vega RB. Reservorio venoso subcutáneo. Cir.parag 2012;36(2):14-16.
Baiocco GG, da Silva, Jefferson Luis Braga. La utilización del catéter central de inserción periférica (CCIP) en el ambiente hospitalario. Rev. Latino-Am. Enfermagem 2010; 18(6):[07 pantallas].
Ince E, Oguzkurt P, Temiz A, Ezer S, Gezer H, Yazici N, et al. Complications of total implantable access ports and efficacy of Taurolidine-citrate lock solution against catheter-related infections. Afr J Paediatr Surg. Apr-Jun 2014;11(2):138-42.
Granziera E, Scarpa M, Ciccarese A, Filip B, Cagol M, Manfredi V, et al. Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution. BMC Surgery 2014;14:n/a-27.
Shim J, Seo T, Song MG, Cha I, Kim JS, Choi CW, et al. Incidence and risk factors of infectious complications related to implantable venous-access ports. Korean J Radiol. 2014;15(4):494-500.
Seok JP, Kim YJ, Cho HM, Ryu HY, Hwang WJ, Sung TY. A retrospective clinical study: complications of totally implanted central venous access ports. Korean J Thorac Cardiovasc Surg. 2014;47(1):26-31.
de Oliveira EB, Reis MA, Avelar TM, Vieira SC. Totally implantable central venous catheters for chemotherapy: experience with 793 patients. Rev. Col. Bras. Cir. 2013;40(3):186-190
D'Souza PC, Kumar S, Kakaria A, Al-Sukaiti R, Zahid KF, Furrukh M, et al. Use of port-a-cath in cancer patients: a single-center experience. J Infect Dev Ctries 2014 2014;8(11):1476-1482
Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA: CA Cancer J Clin. 2008;58(6):323-346.
Bassi KK, Giri AK, Pattanayak M, Abraham SW, Pandey KK. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients. Indian J Cancer. 2012;49(1):114-118.
Ahn DH, Illum HB, Wang DH, Sharma A, Dowell JE. Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors. J Oncol Pract. 2013;9(1):e8-12.
Hatakeyama N, Hori T, Yamamoto M, Mizue N, Inazawa N, Igarashi K, et al. An evaluation of peripherally inserted central venous catheters for children with cancer requiring long-term venous access. Int J Hematol 2011;94(4):372-7.
Leonidou L, Gogos CA. Catheter-related bloodstream infections: catheter management according to pathogen. Int J Antimicrob Agents. 2010;36:S26-S32.
Kabalan P, Rodríguez N, Tordecilla J, Sepúlveda F. Infecciones de Catéter Venoso Central y Lock Terapia en Pacientes Oncológicos. Rev Chil Pediatr. 2010;81(5):425-431
Kim JT, Oh TY, Chang WH, Jeong YK. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy. Med Oncol. 2012;29(2):1361-1364.
Baskin JL, Pui C, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet. 2009;374(9684):159-169.
Warren P, Burke C. Endovascular management of chronic upper extremity deep vein thrombosis and superior vena cava syndrome. Semin Intervent Radiol. 2011;28(1):32-38.
Liu Y, Gao Y, Wei L, Chen W, Ma X, Song L. Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation. Ther Clin Risk Manag. 2015; 11:153-160.
Bishop L, Dougherty L, Bodenham A, Mansi J, Crowe P, Kibbler C, et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007;29(4):261-278.
Health.qld.gov.au [Internet].The State of Queensland; c1996-2015 [citado 12 abr 2015]. Guideline Peripherally Inserted Central Venous Catheter (PICC); 18. Disponible en: http://www.health.qld.gov.au/qhpolicy/docs/gdl/qh-gdl-321-6-1.pdf
Health.qld.gov.au [Internet].The State of Queensland; c1996-2015 [citado 10 abr 2015]. Guideline Totally Implantable Central Venous Access Ports; 18. Disponible: http://www.health.qld.gov.au/qhpolicy/docs/gdl/qh-gdl-321-6-6.pdf
Freire E, De la Iglesia A, Rodríguez C, López M, González M, Peleteiro R, et al. Reservorios venosos centrales totalmente implantables, tipo Port-A-Cath, en pacientes oncológicos: Revisión de Complicaciones. Rev Soc Esp Dolor 2008;7:451-462.
Kurul S, Saip P, Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 2002 Nov 2002;3(11):684-92.
Matsuzaki A, Suminoe A, Koga Y, Hatano M, Hattori S, Hara T. Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer. 2006;14(2):153-160.
Cotogni P, Barbero C, Garrino C, Degiorgis C, Mussa B, De Francesco A, et al. Peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study. Support Care Cancer. 2015;23(2):403-409.
Sauerland C, Engelking C, Wickham R, Corbi D. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Onc Nurs Society. 2006; 33(6):1134-1141.
Alfaro-Rubio A, Sanmartín O, Requena C, Llombart B, Botella-Estrada R, Nagore E, et al. Extravasación de agentes citostáticos: una complicación grave del tratamiento oncológico. Actas Dermosifiliogr. 2006;97(3):169-176.
Hadaway LC. Preventing extravasation from a central line. Nursing. 2004;34(6):22-3.
Romaniello HO. Incidencia de extravasación del líquido de perfusión por el uso de catéteres percutáneos. Arch.argent.pediatr. 2005;103(1):31-35.
Coramhc.com [Internet]. Coram LLC; c2014 [citado 10 abr 2015]. Your Peripherally Inserted Central Catheter (PICC); 6. Disponible en:
http://www.coramhc.com/patientresources/pdf/Your_PICC.pdf
Madrid.org: Hospital Universitario Ramón y Cajal [Internet]. Comunidad de Madrid; [citado 15 mayo]. Protocolo general Catéteres Venosos Centrales de Inserción Periférica; 7. Disponible en:
Suárez EG, Martínez ARA, Bueno BM. Protocolo para la inserción, mantenimiento y retirada del catéter periférico. 2013
Coady K, Ali M, Sidloff D, Kenningham RR, Ahmed S. A comparison of infections and complications in central venous catheters in adults with solid tumours. J Vasc Access 2015;16(1):38-41.
Seom.org [Internet]. Madrid: Sociedad Española de Oncología Médica; [citado 16 mayo 2015]. Impacto Psicosocial del Cáncer; 3. Disponible en: http://www.seom.org/seomcms/images/stories/recursos/infopublico/publicaciones/revista_contigo/n_6/psicooncologia.pdf
Nagel S, Teichgräber U, Kausche S, Lehmann A. Satisfaction and quality of life: a survey‐based assessment in patients with a totally implantable venous port system. Eur J Cancer Care. 2012;21(2):197-204.
Paleczny J, Banyś-Jafernik B, Gazurek K, Kierpieć K, Szczerba H, Zipser P. Long-term totally implantable venous access port systems - one center experience. Anaesthesiol Intensive Ther. 2013;45(4):215-222.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
